Table 1.
Substrates and inhibitors | NAD(P)H reduction(% of maximum) | Predicted rate of superoxide |
---|---|---|
Production from site IF | ||
(pmol min−1 mg protein−1) | ||
Proline (Fig. 3a) | 5.5±1.9 | 11.0±1.0 |
Proline, malonate (Fig. 3a) | 2.6±1.8 | 10.3±0.6 |
Proline, rotenone (Fig. 3b) | 98.0±1.0 | 67.8±14.7 |
Proline, myxothiazol (Fig. 3b) | 37.9±5.6 | 20.8±8.7 |
Proline, myxothiazol, malonate (Fig. 3b) | 20.8±4.9** | 17.7±5.8 |
Proline, myxothiazol, rotenone, A5, malonate (Fig. 3b) | 100 | 70.4±15.4 |
p=0.007 comparing proline, myxothiazol and proline, myxothiazol and malonate (paired t-test, one-tailed).